Page last updated: 2024-08-26

coumarin 6 and Atherogenesis

coumarin 6 has been researched along with Atherogenesis in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, C; Davis, JR; Di, G; Liao, D; Shi, W; Tang, L; Wang, H; Wu, Z; Zhang, B1

Other Studies

1 other study(ies) available for coumarin 6 and Atherogenesis

ArticleYear
EGFP-EGF1-conjugated poly(lactic-co-glycolic acid) nanoparticles, a new diagnostic tool and drug carrier for atherosclerosis.
    International journal of nanomedicine, 2019, Volume: 14

    Topics: Animals; Aorta; Atherosclerosis; Coumarins; Disease Models, Animal; Drug Carriers; Drug Delivery Systems; Fluorescence; Green Fluorescent Proteins; Humans; Mice, Inbred C57BL; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Nanoparticles; Particle Size; Peptide Elongation Factor G; Polylactic Acid-Polyglycolic Acid Copolymer; Static Electricity; Thiazoles

2019